Methylation levels of sodium–iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression

التفاصيل البيبلوغرافية
العنوان: Methylation levels of sodium–iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression
المؤلفون: Rosalinda Camargo, Ileana Gabriela Sanchez Rubio, Geraldo Medeiros-Neto, Ana Luiza Galrao, Marco Aurélio Vamondes Kulcsar, C. U. Friguglietti, Erika Urbano de Lima, A. K. Sodré
المصدر: Endocrine. 43:225-229
بيانات النشر: Springer Science and Business Media LLC, 2012.
سنة النشر: 2012
مصطلحات موضوعية: Sodium-iodide symporter, Regulation of gene expression, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Promoter, Methylation, Biology, medicine.disease_cause, Endocrinology, CpG site, Internal medicine, Gene expression, DNA methylation, Cancer research, medicine, Carcinogenesis, health care economics and organizations
الوصف: DNA methylation regulates gene expression. Aberrant methylation plays an important role in human tumorigenesis. We have previously detected reduced NIS mRNA expression in thyroid tumors as compared to non-tumor tissues. Thus, in this study we investigated whether the methylation of the CpG-island located in the NIS gene promoter was associated with reduced mRNA expression in thyroid tumors. Methylation levels of 30 pairs of samples from 10 benign and 20 malignant thyroid tumors (T) along with matched non-tumor (NT) areas were determined by semiquantitative methylation specific-PCR. NIS methylation was detected in all samples. Methylation levels and frequencies did not differ between the groups and were not associated with BRAF mutational status. Highest methylation levels and frequencies were detected in the 5' region of the CpG-island decreasing toward the 3' end. Intraindividual analysis (T versus NT) showed high tumor methylation levels in 40 % of the samples in the benign group and 30 % in the malignant group, associated with low NIS mRNA expression. No quantitative correlation was detected between methylation levels and mRNA expression in any the groups. The results of this study showed that methylation of NIS promoter is a very frequent event in both benign and malignant tumors as well as in their surrounding tissues, and characterized a non-homogeneous methylation pattern along the CpG island. Therefore, further investigations involving other sites that may be implicated in methylation regulation of NIS expression are warranted.
تدمد: 1559-0100
1355-008X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::22c56a9a220f2b41a3369d126056d5e2
https://doi.org/10.1007/s12020-012-9779-8
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........22c56a9a220f2b41a3369d126056d5e2
قاعدة البيانات: OpenAIRE